BHVN stock was sold by a variety of institutional investors in the last quarter, including Armistice Capital LLC, Alliancebernstein L.P., Columbus Circle Investors, Emerald Advisers LLC, Emerald Mutual Fund Advisers Trust, Candriam Luxembourg S.C.A., Rhenman & Partners Asset Management AB, and Wells Fargo & Company MN. Company insiders that have sold Biohaven Pharmaceutical company stock in the last year include Declan Doogan, Elyse Stock, Gregory Bailey, James Engelhart, John Tilton, John W Childs, Kimberly Gentile, Robert Berman, and William A Jones Jr.
View insider buying and selling activity for Biohaven Pharmaceutical or view top insider-selling stocks.